Adjuvant systemic therapy in older women with breast cancer
Julieta Leone,1 Bernardo Amadeo Leone,1 José Pablo Leone2 1Department of Medical Oncology, Grupo Oncológico Cooperativo del Sur (GOCS), Neuquén, Argentina; 2Department of Internal Medicine, Division of Hematology-Oncology and Blood & Marrow Transplantation, U...
Saved in:
Main Authors: | Leone J, Leone BA, Leone JP |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/8a9ad08e60214e8889f202e54ed37e10 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Are another 5 years of adjuvant aromatase inhibitor therapy needed?
by: Mo QG, et al.
Published: (2016) -
Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study
by: Wako Z, et al.
Published: (2021) -
Time to Adjuvant Chemotherapy and Its Predictors Among Women with Breast Cancer at the University of Gondar Compressive Specialized Hospital: A Retrospective Follow-Up Study
by: Zeleke Alem A, et al.
Published: (2020) -
Resistance and Overcoming Resistance in Breast Cancer
by: Luque-Bolivar A, et al.
Published: (2020) -
Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India
by: Butani D, et al.
Published: (2021)